Age-related Changes in the Prevalence of Precipitating Antibodies to BK Virus in Infants and Children

References

1. Borgatti M., Costanzo F., Portolani M., VuLLO C, OsTi L., Masi M., Barbanti-Brodano G. 1979; Evidence for reactivation of persistent infections during pregnancy and lack of congenital transmission of BK virus, a human papovavirus. Microbiologica 2:173–178
   [Google Scholar]
2. Brown P., Tsai T., Gajdusek D. C. 1975; Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. American Journal of Epidemiology 102:331–340
   [Google Scholar]
3. Cheeseman S. H., Black P. H., Rubin R. H., Cantell K., Hirsch M. S. 1980; Interferon and BK papovavirus. Clinical and laboratory studies. Journal of Infectious Diseases 141:157–161
   [Google Scholar]
4. Coleman D. V., Wolfendale M. R., Daniel R. A., Dhanjal N. K., Gardner S. D., Gibson P. E., Field A. M. 1980; A prospective study of human Polyomavirus infection in pregnancy. Journal of Infectious Diseases 142:1–8
   [Google Scholar]
5. Corallini A.12 others 1976; Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia. Infection and Immunity 13:1684–1691
   [Google Scholar]
6. Dei R., Urbano P. 1982; Immunoelectro-osmophoresis with the human papovavirus BK. Journal of Virological Methods 3:311–318
   [Google Scholar]
7. De Stasio A., Mastromarino P., Pana A., Seganti L., Sinibaldi L., Valenti P., Orsi N. 1980; Characterization of a glycoprotein inhibitor present in human serum and active towards BK virus hemagglutination. Microbiologica 3:293–305
   [Google Scholar]
8. Donini U. 7 others 1981; A search for BK virus immune complexes in human nephropathies: immunological cross-reaction between BK virus structural antigens and human immunoglobulins. Microbiologica 4:87–100
   [Google Scholar]
9. Fiori M., Di Mayorca G. 1976; Occurrence of BK virus DNA in DNA obtained from certain human tumors. Proceedings of the National Academy of Sciences of the United States of America 73:4662–4666
   [Google Scholar]
10. Gardner S. D. 1973; Prevalence in England of antibody to human Polyomavirus (B.A.). British Medical Journal 1:77–78
    [Google Scholar]
11. Gardner S. D. 1977; The new human papovaviruses: their nature and significance. Recent Advances in Clinical Virology 1:93–115
    [Google Scholar]
12. Hogan T. F., Borden E. C, McBain J. A., Padgett B. L., Walker D. L. 1980; Human Polyomavirus infections with JC virus and BK virus in renal transplant patients. Annals of Internal Medicine 92:373–378
    [Google Scholar]
13. Israel M. A., Martin M. A., Takemoto K. K., Howley P. M., Aaronson S. A., Solomon D., Khoury G. 1978; Evaluation of normal and neoplastic human tissue for BK virus. Virology 90:187–196
    [Google Scholar]
14. Lancet Editorial 1978; Has BK Virus found a disease?. Lancet 2:876–877
    [Google Scholar]
15. Mäntjärvi R. A., Meurman O. H., Vihma L., Berglund B. 1973; A human papovavirus (BK), biological properties and sero-epidemiology. Annals of Clinical Research 5:283–287
    [Google Scholar]
16. Merletti L. 1976; Sieroepidemiologia umana del polioma virus BK in Umbria. Bolletino dell’Istituto Sieroterapico Milanese 55:573–576
    [Google Scholar]
17. Padgett B. L., Walker D. L. 1973; Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. Journal of Infectious Diseases 127:467–470
    [Google Scholar]
18. Padgett B. L., Walker D. L. 1976; New human papovaviruses. Progress in Medical Virology 22:1–35
    [Google Scholar]
19. Pana A., D’Arca S. U., Castello C., Maldarizzi B. 1976; Prevalence in the Rome healthy population of antibodies to a human Polyomavirus (BK strain). Bolletino dell’ Istituto Sieroterapico Milanese 55:18–22
    [Google Scholar]
20. Portolani M., Marzocchi A., Barbanti-Brodano G., la Plaça M. 1974; Prevalence in Italy of antibodies to a new human papovavirus (BK virus). Journal of Medical Microbiology 7:543–546
    [Google Scholar]
21. Rziha H. J., Belohradsky B. H., Schneider U., Schwenk H. U., Bornkamm G. W., Hausen H. Z. 1978a; BK virus II. Serologic studies in children with congenital disease and patients with malignant tumors and immunodeficiencies. Medical Microbiology and Immunology 165:83–92
    [Google Scholar]
22. Rziha H. J., Bornkamm G. W., Hausen H. Z. 1978b; BK virus I. Seroepidemiologic studies and serologic response to viral infections. Medical Microbiology and Immunology 165:73–81
    [Google Scholar]
23. Shah K. V., Daniel R. W., Stone K. R., Elliott A. Y. 1978; Investigation of human urogenital tract tumors for papovavirus etiology. Journal of the National Cancer Institute 60:579–582
    [Google Scholar]
24. Shah K. V., Daniel R. W., Warszawski R. M. 1973; High prevalence of antibodies to BK virus, an SV40 related papovavirus in residents of Maryland. Journal of Infectious Diseases 128:784–787
    [Google Scholar]
25. Takemoto K. K., Rabson A. S., Mullarkey M. F., Blaese R. M., Garon C. F., Nelson D. 1974; Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich Syndrome. Journal of the National Cancer Institute 53:1205–1207
    [Google Scholar]
26. Van der Noordaa J., Wertheim-van Dillen P. 1977; Rise in antibodies to human papovavirus BK and clinical disease. British Medical Journal 1:1471
    [Google Scholar]